A 62-year-old male smoker develops progressive dyspnea. CT shows centrilobular emphysema predominantly in the upper lobes. Histologically, alveolar walls are destroyed. Which protease-antiprotease imbalance is responsible, and why is alpha-1 antitrypsin deficiency a separate but related entity?

• A MMP-9 from alveolar macrophages overwhelms TIMP-1 inhibition; AAT deficiency involves mutations in MMP-9
• B Cathepsin G and cystatin C imbalance leads to collagen degradation; AAT deficiency involves cathepsin G substrate specificity change
• C Neutrophil elastase activity exceeds alpha-1 antitrypsin (AAT) inhibitory capacity in smokers due to ROS-mediated oxidation of AAT methionine 358, inactivating it — AAT deficiency replicates this biochemically without smoke ✓
• D Matrix metalloproteinase-12 (macrophage metalloelastase) is the sole effector; alpha-1 antitrypsin inhibits MMP-12 directly

Explanation

In smokers, emphysema results from neutrophil elastase (NE) overwhelming local AAT-mediated inhibition: cigarette smoke ROS oxidize the critical methionine 358 residue in the active site of AAT, converting it from a functional serine protease inhibitor (serpin) to an inactive protein. Unrestrained NE then degrades elastin and alveolar walls. In AAT deficiency (Z or S allele mutations causing protein misfolding and liver polymerization), AAT plasma levels are intrinsically low, producing the same unrestrained NE-mediated protease activity predominantly in lower lobes. MMP-12 also contributes but AAT's primary target is NE.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.